Drug Development

Listings
  • Japan Regulatory Compliance Requirements for Life Science Products

    Japan Regulatory Compliance Requirements for Life Science Products

    Drug Development Seattle (Washington) September 5, 2018 1495.00 Dollar US$

    Course "Japan Regulatory Compliance Requirements for Life Science Products" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: This 2-Day seminar covers the detai...

  • 6-Hour Virtual Seminar on Batch Record Review and Product Release

    6-Hour Virtual Seminar on Batch Record Review and Product Release

    Drug Development Fremont (California) July 3, 2019 545.00 Dollar US$

    Most Regulatory Agencies require firms to have written procedures in place to document production and process controls, better known as batch records. Additionally, there must be written procedures for a batch record review process that demonstrate c...

  • Introduction to Sales and Use Taxation

    Introduction to Sales and Use Taxation

    Drug Development Fremont (California) May 23, 2019 150.00 Dollar US$

    Overview: In this webinar you will Learn how to determine whether the tax basis is equal to the sale of property or sale of services or both (the states are inconsistent), Also Learn the difference between a sales tax and a use tax. Why should you At...

  • Fraud & Abuse, Stark & Anti-Kickback Issues

    Fraud & Abuse, Stark & Anti-Kickback Issues

    Drug Development Fremont (California) December 4, 2019 139.00 Dollar US$

    Overview: The presentation will provide an overview of the Federal Stark and Anti-Kickback laws and corresponding regulations including the history and purpose of these laws. The presenter will provide the background upon which these laws were determ...

  • HIPAA Violations - Social Media, Web Sites, Patient Reviews

    HIPAA Violations - Social Media, Web Sites, Patient Reviews

    Drug Development Fremont (California) March 1, 2019 139.00 Dollar US$

    Overview: Patient Engagement is a cornerstone of quality patient care and Web Sites and Social Media are indispensable patient engagement tools. Provider Web Sites and Social Media are inexpensive, easy to build and almost universal today. HIPAA law ...

  • Dealing with the Disruptive Practitioner in a Legally Compliant Manner

    Dealing with the Disruptive Practitioner in a Legally Compliant Manner

    Drug Development Fremont (California) March 1, 2019 139.00 Dollar US$

    Overview: Disruptive activity by practitioners in the hospital takes many forms. When it happens, it is important that the hospital and/or the medical staff take appropriate steps to see that it does not affect patient care or disrupt operations. Why...

  • Clinical Documentation Improvement: Moving to Improve Patient Outcomes

    Clinical Documentation Improvement: Moving to Improve Patient Outcomes

    Drug Development Fremont (California) March 1, 2019 139.00 Dollar US$

    Overview: Achieving high performing quality focused patient centered cost-effective outcomes based clinical care requires a multidisciplinary approach to delivering patient care. Why should you Attend: Accurate reporting and reflection of patient out...

  • Employee Engagement that Works

    Employee Engagement that Works

    Drug Development Fremont (California) May 27, 2019 110.00 Dollar US$

    Overview The greatest difference in today's workplace is the Death of Control. The employee you can control…you don't want working for you! (They'll expect you to be their mommy or daddy. I don't know about you, but I already have enough kids.) Contr...

  • UBE2L3  peptide

    UBE2L3 peptide

    Drug Development Shirley (New York) December 21, 2018 86.00 Dollar US$

    The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-co...

  • E. coli Galactosidase alpha [His]

    E. coli Galactosidase alpha [His]

    Drug Development Shirley (New York) October 25, 2019 10.00 Dollar US$

    Alpha-galactosidase is a glycoside hydrolase enzyme that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. It is encoded by the GLA gene. This enzyme is a homodimeric glycoprotein that hydrolyses the terminal alpha...

  • M. Tuberculosis CFP10

    M. Tuberculosis CFP10

    Drug Development Shirley (New York) September 24, 2019 10.00 Dollar US$

    CFP10 is an antigen that contributes to the virulence Mycobacterium tuberculosis. CFP-10 forms a tight 1:1 heterodimeric complex with 6kDaA early secreted antigen target (ESAT-6). In the mycobacterial cell, these two proteins are interdependent on ea...

  • M. Tuberculosis 16 kDa

    M. Tuberculosis 16 kDa

    Drug Development Shirley (New York) September 24, 2019 10.00 Dollar US$

    Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the family Mycobacteriaceae and the causative agent of most cases of tuberculosis (TB). First discovered in 1882 by Robert Koch, M. tuberculosis has an unusual, waxy coating on its...